Bristol-Myers Squibb Co. insider trading
In the last twelve months insiders at Bristol-Myers Squibb Co. filed 4 open-market sales worth $2.3 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Massacesi Cristian, EVP,Chief Med Offr,Head of Dev, sold 6,249 shares at $64.57 on 9 September 2026, filed 10 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 9 September 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Sale | 6,249 | $64.57 | $403,498 | Form 4 |
| 25 August 2026 | Holzer Phil M | SVP and Controller | Sale | 500 | $67.50 | $33,750 | Form 4 |
| 1 April 2026 | Elkins David V | EVP, Chief Financial Officer | Sale | 25,519 | $61.60 | $1.6 million | Form 4 |
| 1 April 2026 | Elkins David V | EVP, Chief Financial Officer | Sale | 4,481 | $62.05 | $278,046 | Form 4 |
Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Bristol-Myers Squibb Co.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.